NAPROXEN — all Canadian products
90 DINs
27 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NAPROXEN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00522651 | APO-NAPROXEN | APOTEX INC | Tablet | Oral | NAPROXEN 250 MG | Marketed | |
| 00600806 | APO-NAPROXEN | APOTEX INC | Tablet | Oral | NAPROXEN 375 MG | Marketed | |
| 00592277 | APO-NAPROXEN | APOTEX INC | Tablet | Oral | NAPROXEN 500 MG | Marketed | |
| 02564548 | APO-NAPROXEN / ESOMEPRAZOLE | APOTEX INC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 500 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02564521 | APO-NAPROXEN / ESOMEPRAZOLE | APOTEX INC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 375 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02246701 | APO-NAPROXEN EC | APOTEX INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Marketed | |
| 02246700 | APO-NAPROXEN EC | APOTEX INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Marketed | |
| 02246699 | APO-NAPROXEN EC TABLETS | APOTEX INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Marketed | |
| 02568535 | JAMP NAPROXEN | JAMP PHARMA CORPORATION | Tablet | Oral | NAPROXEN 250 MG | Approved | |
| 02568551 | JAMP NAPROXEN | JAMP PHARMA CORPORATION | Tablet | Oral | NAPROXEN 500 MG | Approved | |
| 02568543 | JAMP NAPROXEN | JAMP PHARMA CORPORATION | Tablet | Oral | NAPROXEN 375 MG | Approved | |
| 02443449 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | MYLAN PHARMACEUTICALS ULC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 500 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02458608 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | MYLAN PHARMACEUTICALS ULC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 375 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02162423 | NAPROSYN | SEARCHLIGHT PHARMA INC | Tablet (Delayed-Release) | Oral | NAPROXEN 500 MG | Marketed | |
| 02162466 | NAPROSYN | SEARCHLIGHT PHARMA INC | Tablet (Extended-Release) | Oral | NAPROXEN 750 MG | Marketed | |
| 02162431 | PEDIAPHARM NAPROXEN SUSPENSION | MEDEXUS PHARMACEUTICALS INC. | Suspension | Oral | NAPROXEN 25 MG | Marketed | |
| 02310953 | PRO-NAPROXEN EC | PRO DOC LIMITEE | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Marketed | |
| 00589861 | TEVA-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 500 MG | Marketed | |
| 00627097 | TEVA-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 375 MG | Marketed | |
| 00565350 | TEVA-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 250 MG | Marketed | |
| 02243314 | TEVA-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Marketed | |
| 02243312 | TEVA-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Marketed | |
| 02243313 | TEVA-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Marketed | |
| 02361728 | VIMOVO | XEDITON PHARMACEUTICALS INC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 500 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02361701 | VIMOVO | XEDITON PHARMACEUTICALS INC | Tablet (Immediate- And Delayed-Release) | Oral | NAPROXEN 375 MG; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE) 20 MG | Marketed | |
| 02463679 | WAYMADE-NAPROXEN | WAYMADE PLC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Approved | |
| 02463687 | WAYMADE-NAPROXEN | WAYMADE PLC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Approved | |
| 00522678 | APO NAPROXEN TAB 125MG | APOTEX INC | Tablet | Oral | NAPROXEN 125 MG | Dormant | |
| 02177072 | APO-NAPROXEN SR TABLETS 750MG | APOTEX INC | Tablet (Extended-Release) | Oral | NAPROXEN 750 MG | Dormant | |
| 02365847 | AVA-NAPROXEN EC | AVANSTRA INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02365863 | AVA-NAPROXEN EC | AVANSTRA INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02243431 | MYLAN-NAPROXEN EC | MYLAN PHARMACEUTICALS ULC | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02243432 | MYLAN-NAPROXEN EC | MYLAN PHARMACEUTICALS ULC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02241024 | MYLAN-NAPROXEN EC | MYLAN PHARMACEUTICALS ULC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02162415 | NAPROSYN | SEARCHLIGHT PHARMA INC | Tablet (Delayed-Release) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 00335193 | NAPROSYN 250MG | SYNTEX INC. | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02162474 | NAPROSYN 250MG TABLETS | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 00583367 | NAPROSYN 375MG | SYNTEX INC. | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02162482 | NAPROSYN 375MG TABLETS | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02162458 | NAPROSYN 500 MG SUPPOSITORIES | HOFFMANN-LA ROCHE LIMITED | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 02162490 | NAPROSYN 500 MG TABLETS | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02162792 | NAPROSYN E 250MG TABLETS - ECT | HOFFMANN-LA ROCHE LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 01937340 | NAPROSYN E TAB 250MG | SYNTEX INC. | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 01937359 | NAPROSYN E TAB 375MG | SYNTEX INC. | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 01937332 | NAPROSYN E TAB 500MG | SYNTEX INC. | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 00531022 | NAPROSYN SUP 500MG | SYNTEX INC. | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 00587923 | NAPROSYN SUS 25MG/ML | SYNTEX INC. | Suspension | Oral | NAPROXEN 25 MG | Cancelled Post Market | |
| 00788767 | NAPROSYN-SR TAB 750MG | SYNTEX INC. | Tablet (Extended-Release) | Oral | NAPROXEN 750 MG | Cancelled Post Market | |
| 02350769 | NAPROXEN | SANIS HEALTH INC | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02350750 | NAPROXEN | SANIS HEALTH INC | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02350777 | NAPROXEN | SANIS HEALTH INC | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 00590762 | NAPROXEN - 250 | PRO DOC LIMITEE | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 00618721 | NAPROXEN - 500 | PRO DOC LIMITEE | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 00590754 | NAPROXEN 125 TAB 125MG | PRO DOC LIMITEE | Tablet | Oral | NAPROXEN 125 MG | Cancelled Post Market | |
| 02350785 | NAPROXEN EC | SANIS HEALTH INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02350807 | NAPROXEN EC | SANIS HEALTH INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02350793 | NAPROXEN EC | SANIS HEALTH INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02539969 | NAPROXEN LIQUID GELS | JUNO OTC INC | Capsule | Oral | NAPROXEN 200 MG | Cancelled Pre Market | |
| 00655686 | NAPROXEN-375 | PRO DOC LIMITEE | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 00565369 | NOVO-NAPROX TAB 125MG | NOVOPHARM LIMITED | Tablet | Oral | NAPROXEN 125 MG | Cancelled Post Market | |
| 02346591 | NTP-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 375 MG | Cancelled Pre Market | |
| 02346605 | NTP-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 500 MG | Cancelled Pre Market | |
| 02346583 | NTP-NAPROXEN | TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 250 MG | Cancelled Pre Market | |
| 02346621 | NTP-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Pre Market | |
| 02346613 | NTP-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Pre Market | |
| 02346648 | NTP-NAPROXEN EC | TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Pre Market | |
| 02336553 | NU-NAPROX EC | NU-PHARM INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled (Unreturned Annual) | |
| 02336588 | NU-NAPROX EC | NU-PHARM INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled (Unreturned Annual) | |
| 02336561 | NU-NAPROX EC | NU-PHARM INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled (Unreturned Annual) | |
| 00865621 | NU-NAPROX TAB 125MG | NU-PHARM INC | Tablet | Oral | NAPROXEN 125 MG | Cancelled Post Market | |
| 00865648 | NU-NAPROX TAB 250MG | NU-PHARM INC | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 00865656 | NU-NAPROX TAB 375MG | NU-PHARM INC | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 00865664 | NU-NAPROX TAB 500MG | NU-PHARM INC | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02017237 | PMS-NAPROXEN | PHARMASCIENCE INC | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 02294702 | PMS-NAPROXEN EC | PHARMASCIENCE INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02294710 | PMS-NAPROXEN EC | PHARMASCIENCE INC | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02310945 | PRO-NAPROXEN EC - 375 | PRO DOC LIMITEE | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 00615331 | RATIO-NAPROXEN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 00615315 | RATIO-NAPROXEN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 00756814 | RATIO-NAPROXEN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 00615323 | RATIO-NAPROXEN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02231006 | RATIO-NAPROXEN E | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 500 MG | Cancelled Pre Market | |
| 02231005 | RATIO-NAPROXEN E | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 375 MG | Cancelled Pre Market | |
| 02231004 | RATIO-NAPROXEN E | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Enteric-Coated) | Oral | NAPROXEN 250 MG | Cancelled Pre Market | |
| 02229690 | RHODIAPROX - 500MG/SUP | RHODIAPHARM INC | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 02240786 | RIVA-NAPROXEN | LABORATOIRE RIVA INC. | Tablet | Oral | NAPROXEN 250 MG | Cancelled Post Market | |
| 02240787 | RIVA-NAPROXEN | LABORATOIRE RIVA INC. | Tablet | Oral | NAPROXEN 375 MG | Cancelled Post Market | |
| 02240788 | RIVA-NAPROXEN | LABORATOIRE RIVA INC. | Tablet | Oral | NAPROXEN 500 MG | Cancelled Post Market | |
| 02230477 | SAB-NAPROXEN | SABEX INC | Suppository | Rectal | NAPROXEN 500 MG | Cancelled Post Market | |
| 02231327 | TEVA-NAPROXEN SR | TEVA CANADA LIMITED | Tablet (Extended-Release) | Oral | NAPROXEN 750 MG | Cancelled Post Market |
Browse other molecules: